Drug Discovery

Cancer cells
#BioIVT #Cancer research #Drug development #Drug discovery #iOnctura #Kazia Therapeutics #Sartorius #Vyriad Therapeutics #Webinar

Drug discovery challenges in cancer research webinar

Hosted by Drug Discovery World and supported by Sartorius and BioIVT, this webinar will explore the opportunities and challenges that exist within cancer research drug discovery and development. You will hear from Karol Budzik, PhD, Business Development Associate at Vyriad Therapeutics and Lars van der Veen, Chief Scientific Officer at… Read More

#News

#AI / data analytics / healthtech / informatics #Drug discovery #Infectious diseases #Lab automation #Organoids #UK

New robotic AI lab opens in Liverpool to help fight infectious diseases  

The UK’s first high-security robotic AI laboratory designed to accelerate the discovery of drugs and vaccines for infectious diseases has opened in Liverpool.   The £20 million Liverpool Accelerate Laboratory has been developed through the Infection Innovation Consortium: iiCON, which advances pioneering infection R&D through collaboration between industry, researchers and the NHS. It… Read More

#News

#Automation #Chromatography #Drug discovery #Purification technology #Webinar

Last chance to register: Rethinking protein purification

Join this webinar, hosted by DDW and supported by Cytiva, to learn how automation, parallel chromatography, and smart software features can help scientists increase throughput, reduce hands-on time, and maintain consistent purification performance. Join for free on Tuesday, September 15 to learn: How parallel chromatography can be used to process… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (7-11 September 2026) 

News round-up for 7-11 September 2026 by Megan Thomas, Content Team at DDW.  This week’s news roundup covers upcoming Drug Discovery Innovators & Investors (DDII) in-person events and forum updates, alongside the latest Phase II clinical data across coeliac disease, bronchiectasis and head and neck cancer. Read More

#News

#DDII #DDIIDigitalForum #DDIIeventseries #Drug discovery #Drug discovery events #Drug Discovery Innovators & Investors #Events

Drug Discovery Innovators & Investors Digital Forum offers certificate of attendance

Join us on 30 September for the Drug Discovery Innovators & Investors (DDII) Digital Forum, where experts from across the drug discovery ecosystem explore the technologies, strategies, therapies and investment trends shaping early-stage drug discovery. The Forum is free to attend. Register for the full event, or simply join one… Read More

#News

#DDII #DDIIDigitalForum #DDIIeventseries #Drug discovery #Drug discovery events #Drug Discovery Innovators & Investors #Events

Five reasons to attend Drug Discovery Innovators & Investors, London

The Drug Discovery Innovators & Investors (DDII) London, UK Conference brings together pharma and biotech companies, technology suppliers, academia, start-ups, spin-outs and investors for a focused day of discussion, collaboration and networking. Taking place at etc.venues in Monument, London, UK on Wednesday 4 November 2026, the conference will examine the… Read More

#News

GPCRs
#Drug discovery #GPCRs #Oncology

eBook: Insights into GPCR drug discovery & development 

G protein-coupled receptors (GPCRs) form one of the largest drug target families, with 516 approved drugs targeting GPCRs. They play a central role in cellular signalling pathways, including neurotransmission, immune response and metabolic regulation, making them key targets for therapeutic intervention. Currently approved drugs act on 121 GPCR… Read More

#News

#BioIVT #Cancer research #Drug development #Drug discovery #iOnctura #Kazia Therapeutics #Sartorius #Vyriad Therapeutics #Webinar

Register to learn about the drug discovery challenges in cancer research

Hosted by Drug Discovery World and supported by Sartorius and BioIVT, this webinar will explore the opportunities and challenges that exist within cancer research drug discovery and development. You will hear from Dr Sudha Rao, Chief Scientific Officer of Kazia Therapeutics, Karol Budzik, PhD, Business Development Associate at Vyriad Therapeutics… Read More

#News

Cancer cells
#Drug discovery #Epigenetics #Genomics #Oncology

How Oryzon Genomics is using epigenetics to tackle cancer  

DDW Editor Reece Armstrong speaks to Dr Carlos Buesa, Founder and CEO of Oryzon Genomics, about epigenetic approaches to treating cancer and the company’s current journey within drug discovery and development.   RA: Can an epigenetic approach help tackle aggressive cancers and those with poor prognoses?  CB: Yes. Many aggressive cancers are… Read More

#Exclusive Content

Neuroscience concept
#Biomarkers #Drug discovery #Neuroscience

What broken livers taught me about the brain 

Jack O’Meara CEO and Co-Founder of Aerska, compares the cardiovascular field to advances in neuroscience and how a preventative approach could be on the horizon for diseases such as Alzheimer’s.   At Ochre Bio, the company I ran before Aerska, we spent years keeping human livers alive outside the body. Organs turned down for transplant, hooked up to… Read More

#Exclusive Content

Human liver
#Cell Science #Drug discovery #New approach methodologies (NAMs) #Organoids #Preclinical development

Download the Factsheet: MASLD research needs better liver models

A new resource is now available to download for free. MASLD drug development is limited by models that don’t reflect human liver biology. HUB’s patient-derived liver organoids retain donor genetics, architecture and physiology. Download the Factsheet to learn: How organoids recapitulate steatosis and fibrosis Which readouts support target validation… Read More

#News

#BioInnovation Institute #Drug discovery #Funding #Investment

BII allocates eight million euros to three drug discovery companies

Six promising companies will receive additional funding of €1.3 ($1.5) million each from BioInnovation Institute (BII) to help them bring their technologies and products closer to market.  The six companies – PanTarg, 3Sonic, Inia Biosciences, Yngvi Bio, Proxi Biotech and Sagava – have all previously received €0.5… Read More

#Business & Investment #News

#Automation #Chromatography #Drug discovery #Purification technology #Webinar

Upcoming webinar rethinks protein purification

Join this webinar, hosted by DDW and supported by Cytiva, to learn how automation, parallel chromatography, and smart software features can help scientists increase throughput, reduce hands-on time, and maintain consistent purification performance. Join for free on Tuesday, September 15 to learn: How parallel chromatography can be used to process… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (31 August – 4 September 2026) 

News round-up for 31 August – 4 September 2026 by Megan Thomas, Content Team at DDW.  This week’s news roundup covers new developments in vaccines, drug approvals, cardiovascular therapies and cancer drug response, alongside DDW’s upcoming digital forum focused on the technologies, strategies and investment trends shaping… Read More

#News